{content}

Study list

Caldrer

Italy
|
2022-2022
  • Adults (18-64 years)
  • General population
  • People at high risk of STIs
  • Men who have sex with men
  • Hospital
  • Infectious diseases unit
  • Monkeypox virus
  • Mpox
  • Sexually transmitted infection
  • Blood sample
  • Serum sample

Catalano

Italy
|
2022-2023
  • Adults (18-64 years)
  • General population
  • Outpatient clinic
  • STD/STI clinic
  • Monkeypox virus
  • Chlamydia trachomatis
  • Neisseria gonorrhoeae
  • Treponema pallidum
  • HIV
  • Mycoplasma spp.
  • Trichomonas vaginalis
  • Ureaplasma
  • Hepatitis B virus
  • Hepatitis C virus
  • Herpes simplex virus
  • Mpox
  • Syphilis
  • Chlamydia
  • Gonorrhoea
  • Mycoplasma infection
  • Ureaplasma infection
  • Genital herpes
  • Hepatitis B
  • Hepatitis C
  • HIV infection
  • Trichomoniasis

ITM Antwerp Mpox Cohort

Belgium
|
2022
  • Adults (18-64 years)
  • General population
  • People at high risk of STIs
  • Outpatient clinic
  • Non-hospital health centre
  • STD/STI clinic
  • Monkeypox virus
  • Mpox

Joseph

Switzerland
|
2022-2024
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • Respiratory syncytial virus
  • Respiratory syncytial virus infection

MOSAIC

Norway Italy Spain Belgium United Kingdom France Portugal Switzerland Singapore The Netherlands Ireland
|
2022-2023
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • Outpatient clinic
  • STD/STI clinic
  • Monkeypox virus
  • Mpox
  • Blood sample
  • Nasopharyngeal swab
  • Skin lesion swab

Moschese

Italy
|
2022-2022
  • Adults (18-64 years)
  • People at high risk of STIs
  • Outpatient clinic
  • Non-hospital health centre
  • STD/STI clinic
  • Monkeypox virus
  • Mpox

mpox-ICONA

Italy
|
2022-2023
  • Adults (18-64 years)
  • People at high risk of STIs
  • People living with HIV
  • Hospital
  • Infectious diseases unit
  • Monkeypox virus
  • Mpox

Nozza

Italy
|
2022-2022
  • Adults (18-64 years)
  • People at high risk of STIs
  • Men who have sex with men
  • Outpatient clinic
  • Non-hospital health centre
  • STD/STI clinic
  • Monkeypox virus
  • Mpox

POINTED-AD

Germany
|
2022-2023
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Infants (<1 year)
  • Adolescents (12-17 years)
  • Children (1-11 years)
  • SARS-CoV-2
  • Post COVID-19 condition

Svartstein

Denmark
|
2022-2022
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • Fragile population
  • People at high risk of STIs
  • Men who have sex with men
  • People living with HIV
  • Hospital
  • Outpatient clinic
  • Infectious diseases unit
  • Monkeypox virus
  • Mpox

MUSLOC

United Kingdom
|
2022-2024
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • Community
  • SARS-CoV-2
  • Post COVID-19 condition

PuRe-COVID

Belgium
|
2022-2024
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Primary care
  • SARS-CoV-2
  • Post COVID-19 condition
  • Non pharmacological intervention
  • Rehabilitation

Schlosser

Germany
|
2022
  • Fragile population
  • Immunocompromised host
  • SARS-CoV-2
  • Post COVID-19 condition

EXPLAIN

United Kingdom
|
2022
  • Adults (18-64 years)
  • General population
  • Hospital
  • Outpatient clinic
  • SARS-CoV-2
  • Post COVID-19 condition

MEGA-Covid-19

Germany
|
2022
  • General population
  • Adolescents (12-17 years)
  • Children (1-11 years)
  • SARS-CoV-2
  • Post COVID-19 condition

Caso

Spain
|
2022-2022
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • Fragile population
  • Immunocompromised host
  • Hospital
  • Outpatient clinic
  • SARS-CoV-2
  • Acute COVID-19
  • Pharmacological intervention
  • Antivirals
  • Nirmatrelvir/Ritonavir

ITIT

Switzerland
|
2022-2025
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • Travelers
  • Community
  • Telemedicine
  • Arbovirus
  • Chikungunya virus
  • Vector-borne
  • Dengue virus
  • West Nile virus
  • Arboviral disease
  • Vector-borne disease
  • Post-acute infection syndrome
  • Non pharmacological intervention
  • Digital health

Lihou

United Kingdom
|
2022-2023
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • Respiratory syncytial virus
  • Respiratory syncytial virus infection

Mertens

Germany
|
2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • Outpatient clinic
  • SARS-CoV-2
  • Post COVID-19 condition

PostCoV2Psy

Portugal
|
2022-2023
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Outpatient clinic
  • SARS-CoV-2
  • Post COVID-19 condition

Rief

Germany
|
2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • SARS-CoV-2
  • Post COVID-19 condition
  • Non pharmacological intervention
  • Rehabilitation

STIMULATECOVID

Spain
|
2022-2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Outpatient clinic
  • SARS-CoV-2
  • Post COVID-19 condition
  • Non pharmacological intervention
  • Neuromodulation

Stubbe

Germany
|
2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • Outpatient clinic
  • SARS-CoV-2
  • Post COVID-19 condition

Solan

Spain
|
2022-2023
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Outpatient clinic
  • SARS-CoV-2
  • Post COVID-19 condition
  • Non pharmacological intervention
  • Rehabilitation